Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-017449
Filing Date
2022-03-09
Accepted
2022-03-09 10:37:52
Documents
1
Period of Report
2022-03-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3159
  Complete submission text file 0001209191-22-017449.txt   4623
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
Cohen Yuval (Reporting) CIK: 0001626003 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 22724311